cervical cancer Clinical Trials and Research
Also known as: cervix cancer, cancer of the cervix uteri, squamous cell carcinoma of the cervix, adenocarcinoma of the cervix, cxca · ICD-10: C53
Cervical cancer develops in the cells of the cervix, the lower part of the uterus. Clinical trials are exploring new therapies, improved screening methods, and prevention strategies, particularly for HPV-related cancers. Find a Trial helps patients search for active studies.
Search cervical cancer trials →
Common questions about cervical cancer clinical trials
What types of clinical trials are currently researching cervical cancer?
Clinical trials for cervical cancer investigate new treatments like immunotherapies and targeted drugs, improved radiation or chemotherapy regimens, and novel surgical techniques. Research also focuses on better screening methods and HPV prevention strategies, according to data from ClinicalTrials.gov and NIH RePORTER.
Who is eligible to participate in cervical cancer clinical trials?
Eligibility criteria vary greatly depending on the specific study, often including factors like cancer stage, previous treatments, overall health, and age. Patients interested in participating should review the detailed criteria for each trial on platforms like ClinicalTrials.gov.
What are common research directions for advanced cervical cancer?
For advanced cervical cancer, research often explores novel systemic therapies such as checkpoint inhibitors, other immunotherapies, and targeted agents designed to block specific cancer growth pathways. Studies also investigate combinations of existing treatments to improve outcomes, as seen on ClinicalTrials.gov.
Do clinical trials for cervical cancer involve HPV testing?
Yes, because most cervical cancers are caused by human papillomavirus (HPV), many clinical trials include HPV testing for diagnosis, prognosis, or to evaluate vaccine effectiveness. Understanding HPV status can guide treatment decisions and research pathways, according to ClinicalTrials.gov.
What are the phases of clinical trials for cervical cancer treatments?
Clinical trials progress through phases: Phase 1 tests safety, Phase 2 evaluates effectiveness and side effects, and Phase 3 compares new treatments to standard ones. Phase 4 monitors approved treatments long-term. Each phase gathers crucial data, as described on ClinicalTrials.gov.
Are there clinical trials focused on preventing cervical cancer?
Yes, prevention is a key area of research, primarily focusing on HPV vaccines and improved screening methods like enhanced Pap tests or HPV co-testing. These studies aim to reduce the incidence of cervical cancer by stopping its development early, according to NIH RePORTER.
What are common exclusion criteria in cervical cancer trials?
Common exclusion criteria can include certain pre-existing medical conditions, specific prior treatments that might interfere with the study drug, or pregnancy. These criteria ensure patient safety and the integrity of the study results, as detailed on ClinicalTrials.gov.
Do patients have to pay to participate in cervical cancer clinical trials?
Generally, study-related medical care, tests, and drugs are provided at no cost to participants. However, patients may be responsible for routine medical care not directly related to the trial, or for travel expenses. Financial policies vary by study.
How to find a cervical cancer trial that fits you
- Describe your cervical cancer situation in detail — stage if applicable, prior treatments, age, and other relevant conditions.
- Use the location filter (worldwide, US, US & Canada, Europe) to narrow to trials near you.
- Review each trial's eligibility criteria carefully. Save 2–5 candidates with their NCT numbers.
- Discuss with your treating clinician before contacting the research site.
Browse all cervical cancer trials →